Cargando…

Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca(2+)-dependent eNOS activation

Although arginase primarily participates in the last reaction of the urea cycle, we have previously demonstrated that arginase II is an important cytosolic calcium regulator through spermine production in a p32-dependent manner. Here, we demonstrated that rhaponticin (RPT) is a novel medicinal-plant...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, Bon-Hyeock, Lee, Jonghoon, Jin, Younghyun, Lim, Hyun Kyo, Ryoo, Sungwoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560459/
https://www.ncbi.nlm.nih.gov/pubmed/34078530
http://dx.doi.org/10.5483/BMBRep.2021.54.10.053
_version_ 1784592937981575168
author Koo, Bon-Hyeock
Lee, Jonghoon
Jin, Younghyun
Lim, Hyun Kyo
Ryoo, Sungwoo
author_facet Koo, Bon-Hyeock
Lee, Jonghoon
Jin, Younghyun
Lim, Hyun Kyo
Ryoo, Sungwoo
author_sort Koo, Bon-Hyeock
collection PubMed
description Although arginase primarily participates in the last reaction of the urea cycle, we have previously demonstrated that arginase II is an important cytosolic calcium regulator through spermine production in a p32-dependent manner. Here, we demonstrated that rhaponticin (RPT) is a novel medicinal-plant arginase inhibitor and investigated its mechanism of action on Ca(2+)-dependent endothelial nitric oxide synthase (eNOS) activation. RPT was uncompetitively inhibited for both arginases I and II prepared from mouse liver and kidney. It also inhibited arginase activity in both aorta and human umbilical vein endothelial cells (HUVECs). Using both microscope and FACS analyses, RPT treatments induced increases in cytosolic Ca(2+) levels using Fluo-4 AM as a calcium indicator. Increased cytosolic Ca(2+) elicited the phosphorylations of both CaMKII and eNOS Ser1177 in a time-dependent manner. RPT incubations also increased intracellular L-arginine (L-Arg) levels and activated the CaMKII/AMPK/Akt/eNOS signaling cascade in HUVECs. Treatment of L-Arg and ABH, arginase inhibitor, increased intracellular Ca(2+) concentrations and activated CaMKII-dependent eNOS activation in ECs of WT mice, but, the effects were not observed in ECs of inositol triphosphate receptor type 1 knockout (IP3R1(−/−)) mice. In the aortic endothelium of WT mice, RPT also augmented nitric oxide (NO) production and attenuated reactive oxygen species (ROS) generation. In a vascular tension assay using RPT-treated aortic tissue, cumulative vasorelaxant responses to acetylcholine (Ach) were enhanced, and phenylephrine (PE)-dependent vasoconstrictive responses were retarded, although sodium nitroprusside and KCl responses were not different. In this study, we present a novel mechanism for RPT, as an arginase inhibitor, to increase cytosolic Ca(2+) concentration in a L-Arg-dependent manner and enhance endothelial function through eNOS activation.
format Online
Article
Text
id pubmed-8560459
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-85604592021-11-12 Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca(2+)-dependent eNOS activation Koo, Bon-Hyeock Lee, Jonghoon Jin, Younghyun Lim, Hyun Kyo Ryoo, Sungwoo BMB Rep Article Although arginase primarily participates in the last reaction of the urea cycle, we have previously demonstrated that arginase II is an important cytosolic calcium regulator through spermine production in a p32-dependent manner. Here, we demonstrated that rhaponticin (RPT) is a novel medicinal-plant arginase inhibitor and investigated its mechanism of action on Ca(2+)-dependent endothelial nitric oxide synthase (eNOS) activation. RPT was uncompetitively inhibited for both arginases I and II prepared from mouse liver and kidney. It also inhibited arginase activity in both aorta and human umbilical vein endothelial cells (HUVECs). Using both microscope and FACS analyses, RPT treatments induced increases in cytosolic Ca(2+) levels using Fluo-4 AM as a calcium indicator. Increased cytosolic Ca(2+) elicited the phosphorylations of both CaMKII and eNOS Ser1177 in a time-dependent manner. RPT incubations also increased intracellular L-arginine (L-Arg) levels and activated the CaMKII/AMPK/Akt/eNOS signaling cascade in HUVECs. Treatment of L-Arg and ABH, arginase inhibitor, increased intracellular Ca(2+) concentrations and activated CaMKII-dependent eNOS activation in ECs of WT mice, but, the effects were not observed in ECs of inositol triphosphate receptor type 1 knockout (IP3R1(−/−)) mice. In the aortic endothelium of WT mice, RPT also augmented nitric oxide (NO) production and attenuated reactive oxygen species (ROS) generation. In a vascular tension assay using RPT-treated aortic tissue, cumulative vasorelaxant responses to acetylcholine (Ach) were enhanced, and phenylephrine (PE)-dependent vasoconstrictive responses were retarded, although sodium nitroprusside and KCl responses were not different. In this study, we present a novel mechanism for RPT, as an arginase inhibitor, to increase cytosolic Ca(2+) concentration in a L-Arg-dependent manner and enhance endothelial function through eNOS activation. Korean Society for Biochemistry and Molecular Biology 2021-10-31 2021-10-31 /pmc/articles/PMC8560459/ /pubmed/34078530 http://dx.doi.org/10.5483/BMBRep.2021.54.10.053 Text en Copyright © 2021 by the The Korean Society for Biochemistry and Molecular Biology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Koo, Bon-Hyeock
Lee, Jonghoon
Jin, Younghyun
Lim, Hyun Kyo
Ryoo, Sungwoo
Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca(2+)-dependent eNOS activation
title Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca(2+)-dependent eNOS activation
title_full Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca(2+)-dependent eNOS activation
title_fullStr Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca(2+)-dependent eNOS activation
title_full_unstemmed Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca(2+)-dependent eNOS activation
title_short Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca(2+)-dependent eNOS activation
title_sort arginase inhibition by rhaponticin increases l-arginine concentration that contributes to ca(2+)-dependent enos activation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560459/
https://www.ncbi.nlm.nih.gov/pubmed/34078530
http://dx.doi.org/10.5483/BMBRep.2021.54.10.053
work_keys_str_mv AT koobonhyeock arginaseinhibitionbyrhaponticinincreaseslarginineconcentrationthatcontributestoca2dependentenosactivation
AT leejonghoon arginaseinhibitionbyrhaponticinincreaseslarginineconcentrationthatcontributestoca2dependentenosactivation
AT jinyounghyun arginaseinhibitionbyrhaponticinincreaseslarginineconcentrationthatcontributestoca2dependentenosactivation
AT limhyunkyo arginaseinhibitionbyrhaponticinincreaseslarginineconcentrationthatcontributestoca2dependentenosactivation
AT ryoosungwoo arginaseinhibitionbyrhaponticinincreaseslarginineconcentrationthatcontributestoca2dependentenosactivation